Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -450.46%, near the high end of its 5-year range (-24463.62%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% above its 12-month average of -548.45%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
-548.45%
NET PROFIT MARGIN AVG 3Y
-941.75%
NET PROFIT MARGIN AVG 5Y
-450.46%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 508 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aprea Therapeutics, Inc.
Market Cap
$8.42M
Net Profit Margin
0.00%
TTM Avg
-548.45%
3Y Avg
-941.75%
5Y Avg
-450.46%
Market Cap
$8.18M
Net Profit Margin
N/A
TTM Avg
-206582.99%
3Y Avg
-143015.53%
5Y Avg
-102538.66%
Market Cap
$8.83M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.96M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.91M
Net Profit Margin
-66.29%
TTM Avg
-59.63%
3Y Avg
-44.17%
5Y Avg
-31.01%
Market Cap
$7.89M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.61M
Net Profit Margin
-1977.59%
TTM Avg
-1280.67%
3Y Avg
-1780.71%
5Y Avg
-1415.68%
Market Cap
$7.58M
Net Profit Margin
-0.61%
TTM Avg
-82.77%
3Y Avg
-131.16%
5Y Avg
-372.00%
Market Cap
$7.21M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-19.45%
5Y Avg
-19.45%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aprea Therapeutics, Inc. (APRE) | $8.42M | 0.00% | -548.45% | -941.75% | -450.46% |
| HeartSciences Inc. (HSCS)vs › | $8.18M | N/A | -206582.99% | -143015.53% | -102538.66% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.83M | 0.00% | 0.00% | 0.00% | 0.00% |
| GT Biopharma, Inc. (GTBP)vs › | $7.96M | 0.00% | 0.00% | 0.00% | 0.00% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.91M | -66.29% | -59.63% | -44.17% | -31.01% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.89M | 0.00% | 0.00% | 0.00% | 0.00% |
| Longeveron Inc. (LGVN)vs › | $7.61M | -1977.59% | -1280.67% | -1780.71% | -1415.68% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.58M | -0.61% | -82.77% | -131.16% | -372.00% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.21M | 0.00% | 0.00% | -19.45% | -19.45% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.75M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | -2742.23% |
| 2025-03-31 | -2420.65% |
| 2024-12-31 | -1406.49% |
| 2024-09-30 | -1066.99% |
| 2024-06-30 | -617.92% |
| 2024-03-31 | -738.39% |
| 2023-12-31 | -24463.62% |
| 2023-09-30 | -1003.08% |
| 2023-06-30 | -1305.27% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
